Breast carcinomas arising from a BRCA1 mutation have been shown to be somewhat distinctive, more often high grade and negative for estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (Her2).4, 5. This evidence concerns the gene BRCA1 and breast carcinoma.